Iaso Therapeutics

BiotechnologySeedEast Lansing, USiasotherapeutics.com

Latest round

Seed

Last raised

Dec 2022

Total raised

$0.4M

Investors

2

About Iaso Therapeutics

Founded in 2018 by Xuefei Huang (CSO), and based in Michigan, US, Iaso Therapeutics, Inc. a spin-out of Michigan State University operates as a biotechnology company that develops therapeutics for cancer and infectious diseases treatment. In January 2023, Iaso Therapeutics, Inc. The company has created a proprietary mutant bacteriophage Q (mQ) platform technology that demonstrates a higher immune response in mQ to aid in the development of vaccines against a variety of diseases, including cancer and microbial infections.

Who invested in Iaso Therapeutics

2 investors across 1 round

See all investors in Iaso Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Dec 22, 2022

    Amount

    $0.4M

    Investors

    Locked

Questions about Iaso Therapeutics

Who invested in Iaso Therapeutics?

Iaso Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Iaso Therapeutics raised?

Iaso Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Iaso Therapeutics last raise money?

Iaso Therapeutics's most recent round on record is a Seed, in Dec 2022.

What does Iaso Therapeutics do?

Founded in 2018 by Xuefei Huang (CSO), and based in Michigan, US, Iaso Therapeutics, Inc.

Where is Iaso Therapeutics headquartered?

Iaso Therapeutics is headquartered in East Lansing, US.

Which VCs invest in companies like Iaso Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Iaso Therapeutics's stage. Their profiles are linked below.

Raising like Iaso Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.